
A new oral hair loss pill just cleared phase 2/3 trials. Study investigator Michael Gold, MD, breaks down how VDPHL01 compares to minoxidil and finasteride.

Michael H. Gold, MD, is the founder/director of Gold Skin Care Center, a Nashville-based dermatology practice.

A new oral hair loss pill just cleared phase 2/3 trials. Study investigator Michael Gold, MD, breaks down how VDPHL01 compares to minoxidil and finasteride.